Back to TCRX

MARSHALL WACE, LLP → TCRX

MARSHALL WACE, LLP TCRX Position History

TScan Therapeutics, Inc. • Healthcare

Quarters held
16
Latest value
$82K
Q3 2026
Peak value
$1.8M
First seen
Q4 2023

Dollar value over time

Show data table
PeriodPosition value
Q4 2023$42K
Q4 2023$603K
Q1 2024$1.5M
Q2 2024$1.8M
Q3 2024$13K
Q3 2024$810K
Q4 2024$134K
Q2 2025$37K
Q2 2025$40K
Q3 2025$4K
Q3 2025$81K
Q4 2025$21K
Q4 2025$318K
Q2 2026$674K
Q3 2026$1K
Q3 2026$82K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$82K265.3K——
Q3 2026$1K4.3K——
Q2 2026$674K687.4K——
Q4 2025$318K318.3K——
Q4 2025$21K21.0K——
Q3 2025$81K44.3K——
Q3 2025$4K2.3K——
Q2 2025$40K27.9K——
Q2 2025$37K25.8K——
Q4 2024$134K44.0K——
Q3 2024$810K162.6K——
Q3 2024$13K2.6K——
Q2 2024$1.8M307.5K——
Q1 2024$1.5M191.2K——
Q4 2023$603K103.4K——
Q4 2023$42K7.1K——

Other funds holding TCRX

Other MARSHALL WACE, LLP positions

ETHA

ISHARES-S&P 500

$17B
IAU

ISHARES-S&P 500

$12B
ETHA

ISHARES-S&P 500

$11.5B
IAU

ISHARES-S&P 500

$11.1B
IAU

ISHARES-S&P 500

$10.7B
IAU

ISHARES-S&P 500

$10.3B
IAU

ISHARES-S&P 500

$9.9B
ETHA

ISHARES-S&P 500

$8.4B